. . . . "in tocilizumab recipients 20/34 , 58.82 % than the controls 4/31 , 12.90 % " . "recorded" . "More mild temporary adverse events" . "S&T TWOC Project - version 4" . "2023-06-14T09:01:24.608042"^^ . . "3d1w07zy" . "3d1w07zy-TRIPLE-ABSTRACT-11" . "RSA" . "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" . "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" . . .